Consumer involvement at the MRC Clinical Trials Unit: results of a survey

Claire L. Vale(MRC Clinical Trials Unit at UCL), Bec Hanley(MRC Clinical Trials Unit at UCL), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), Silvia Forcat(MRC Clinical Trials Unit at UCL), Claire Murphy(MRC Clinical Trials Unit at UCL)

Trials

December 1, 2011

10.1186/1745-6215-12-s1-a81

Cited by 1

Related Papers

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

|The Lancet|2009|1.5k

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial

|The Lancet|2009|1.1k

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

|The Lancet|2007|570

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

|The Lancet|2011|420

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

|Journal of Clinical Oncology|2014|261